PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Feb-2023 Equillium to Present at the SVB Securities Annual Global Healthcare Conference Businesswire
07-Feb-2023 Amulet Capital Partners Acquires Eruptr Businesswire
07-Feb-2023 Ankyra Therapeutics Announces Collaboration to Evaluate ANK-101 in Early Clinical Trials Focused on Lung Cancer Businesswire
07-Feb-2023 OmniAb to Participate in Three Upcoming Investor Conferences Businesswire
07-Feb-2023 Interactome Bio Expands to Chicago's Portal Innovations to Further Foster Its Exosomes Research, Production, and Life Science Focused AI Software Development Newswire
07-Feb-2023 Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Feb-2023 Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease Businesswire
07-Feb-2023 Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease Businesswire
07-Feb-2023 Mattiq Launches With Revolutionary Approach to Developing Sustainable Materials Businesswire
07-Feb-2023 Enanta Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference Businesswire
07-Feb-2023 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results Businesswire
07-Feb-2023 Catalent, Inc. Reports Second Quarter Fiscal 2023 Results Businesswire
07-Feb-2023 Freudenberg Medical Expands Medical Tubing Production to Massachusetts Businesswire
07-Feb-2023 KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session Businesswire
07-Feb-2023 Aplantex Announces the Composition of Its C-Suite Businesswire
07-Feb-2023 Nearly Half of Global Consumers Frustrated by the English Language Dominance of the Internet and Technology Businesswire
07-Feb-2023 TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Businesswire
07-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Feb-2023 Genentech Announces Positive Data From Global Phase III Program for Crovalimab in PNH, a Rare, Life-Threatening Blood Condition Businesswire
07-Feb-2023 TPB Acquisition Corporation I and Lavoro Announce Effectiveness of Registration Statement and the Extraordinary General Meeting Date for Shareholders to Approve the Proposed Business Combination Businesswire